碳离子放疗用于蝶窦恶性肿瘤的长期疗效与毒性
该回顾性分析纳入22例接受根治性碳离子放疗的原发蝶窦癌患者,腺样囊性癌最常见(15例,68.2%)。中位随访48.5个月,5年局部控制率和总生存率分别为51.0%和62.7%;4级视力损伤6例,4级脑坏死1例。碳离子放疗对局部晚期蝶窦恶性肿瘤可获得较好临床结局,但因靶区紧邻关键结构,晚期毒性略高。
要点
- 碳离子放疗可用于局部晚期蝶窦恶性肿瘤的根治性治疗。
- 5年局部控制率51.0%,总生存率62.7%。
- 4级视力损伤和4级脑坏死分别见于6例和1例。
核心结论
- 碳离子放疗对局部晚期蝶窦恶性肿瘤可提供较好的临床结局。
- 因靶区与关键结构极近,晚期毒性略高。
研究设计与样本
- 回顾性分析22例接受根治性碳离子放疗的原发蝶窦癌患者。
主要发现
- 腺样囊性癌为最常见组织学类型(15例,68.2%)。
- 中位随访48.5个月。
- 5年局部控制率为51.0%,5年总生存率为62.7%。
- 4级视力损伤见于6例患者,4级脑坏死见于1例患者。
临床怎么用
- 对不适合根治性切除的局部晚期蝶窦恶性肿瘤,可考虑碳离子放疗。
- 治疗计划与随访需重点关注视力和脑坏死等晚期毒性。
局限性
- 回顾性分析,样本量22例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Most of the primary sphenoid sinus tumors present with locally advanced stages with involvement of adjacent critical structures and are not amenable to radical resection. We sought to evaluate the safety and efficacy of carbon-ion radiotherapy (C-ion RT) for sphenoid sinus malignancies. METHODS: This is a retrospective analysis of 22 patients of primary sphenoid carcinomas treated with definitive C-ion RT. RESULTS: Adenoid cystic carcinoma was the most common histology (15 patients, 68.2%). The median follow-up of this cohort was 48.5 months. The actuarial local control and overall survival at 5 years were 51.0% and 62.7%, respectively. Grade 4 visual impairment and grade 4 brain necrosis were seen in six and one patient, respectively. CONCLUSION: C-ion RT can provide a reasonably good clinical outcome in locally advanced sphenoid sinus malignancies with a marginally higher late toxicity profile because of extremely close proximity of the target volume to critical structures.
引用
- Hagiwara Y, Koto M, Bhattacharyya T, et al. Long-term outcomes and toxicities of carbon-ion radiotherapy in malignant tumors of the sphenoid sinus. Head Neck. 2019. PMID: 31584731. doi:10.1002/hed.25965
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。